Legend Capital, a fund management arm of Chinese conglomerate Legend Holdings, has led a $150-million Series E funding round for ClinChoice to help the Sino-US contract research organisation (CRO) expand its business and service offerings globally.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
